Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome

NCT00079677 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

263

Enrollment

INDUSTRY

Sponsor class

Conditions

Obstructive Sleep Apnea
Sleep Hypopnea

Interventions

DRUG: Armodafinil 150 mg/day
DRUG: Placebo

Sponsor

Cephalon